Dr. Deniz Oral, MD

Dr. Oral practices at James W Aston Ambulatory Care Center in Dallas, Texas.

Dr. Oral's NPI, 1730520404, was assigned on July 10, 2013. Dr. Oral graduated from Hacettepe University FOM in 1996. Dr. Oral holds Texas license P3559.

Dr. Oral's primary practice is James W Aston Ambulatory Care Center, at 5303 Harry Hines Blvd, Dallas, TX 75390 in Dallas County. The practice phone is (214) 645-2300.

Dr. Oral's primary practice is James W Aston Ambulatory Care Center in Dallas, Texas. Dr. Oral is also affiliated with William P. Clements Jr. University Hospital. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Oral to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Oral practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Oral's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Oral is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Oral is licensed in Texas.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, dry eye, eye infection or inflammation, glaucoma and glaucoma surgery among the conditions Dr. Oral treats.

CMS data shows 972 Medicare services from Dr. Oral across 13 procedure codes in 2024, for 441 Medicare patients. Medicare paid $51,512 for them.

CMS counts 441 Medicare patients who saw Dr. Oral in 2024. The largest group is 65 to 74, with 207 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Oral's median patient age at 67, with 58% women.

In 2024, Dr. Oral wrote 403 Medicare Part D claims for 108 patients. 64% of them were for generic drugs. CMS names the drug for 358 of them, across 8 drugs with 11 or more claims each, at $21,599 in total drug cost. In 2023, CMS named 169 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Oral for performance year 2024, reported as part of a group. Dr. Oral accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 112 procedures of cataract surgery by Dr. Oral, more than 76% of the clinicians it reports for that procedure.

Dmand AI links 14 papers to Dr. Oral, published from 2006 to 2010. The most frequent topics are Astigmatism, Keratomileusis, Laser In Situ and Visual Acuity. Dr. Oral has published most often in Br J Ophthalmol. Dr. Oral's most frequent co-authors are James Parker McCulley, MD, Robert Wayne Bowman, MD and Kelly K. Haithcock, MD.

CMS Open Payments shows 10 general payments to Dr. Oral from 4 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Glaukos Corporation paid the most, $383.

Dr. Oral graduated from Hacettepe University FOM in 1996.

Dr. Oral is in network with 23 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.